Arcutis Biotherapeutics, Inc.
US ˙ NasdaqGS ˙ US03969K1088

SecurityARQT / Arcutis Biotherapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership15,606 shares
Latest Disclosed Value $ 367,677
Citadel Advisors Llc ownership in ARQT / Arcutis Biotherapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 15,606 shares of Arcutis Biotherapeutics, Inc. (US:ARQT) valued at $367,677 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 155,158 shares of Arcutis Biotherapeutics, Inc.. This represents a change in shares of -89.94% during the quarter. The current value of the position is $331,315 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (ARQT) in the form of stock options. The firm currently holds call options representing 56,900 of underlying shares valued at $1,340,564 USD and put options representing 25,700 of underlying shares valued at $605,492 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ARQT / Arcutis Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 15,606 -139,552 -89.94 368 -91.85 0.0001
2026-02-17 2025-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 155,158 -22,110 -12.47 4,506 34.84 0.0007
2025-11-14 2025-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 177,268 31,775 21.84 3,342 63.85 0.0005
2025-08-14 2025-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 145,493 -164,582 -53.08 2,040 -57.95 0.0004
2025-05-15 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 310,075 220,907 247.74 4,850 290.42 0.0009
2025-02-14 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 89,168 -2,941,905 -97.06 1,242 -95.59 0.0002
2024-11-14 2024-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 3,031,073 98,426 3.36 28,189 3.35 0.0054
2024-08-14 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 2,932,647 1,018,377 53.20 27,274 43.77 0.0055
2024-05-15 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 1,914,270 1,914,270 18,970 0.0037
2024-02-14 2023-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 0 -250,535 -100.00 0 -100.00
2023-11-14 2023-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 250,535 196,127 360.47 1,330 156.76 0.0003
2023-08-14 2023-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 54,408 -217,113 -79.96 519 -82.65 0.0001
2023-05-15 2023-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 271,521 261,888 2,718.65 2,987 2,002.82 0.0007
2023-02-14 2022-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 9,633 -70,882 -88.04 143 -90.77 0.0000
2022-11-14 2022-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 80,515 -111,996 -58.18 1,539 -62.48 0.0004
2022-08-15 2022-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 192,511 15,811 8.95 4,102 20.54 0.0011
2022-05-16 2022-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 176,700 -70,215 -28.44 3,403 -33.55 0.0007
2022-02-14 2021-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 246,915 -19,017 -7.15 5,121 -19.39 0.0010
2021-11-15 2021-09-30 13F ARCUTIS BIOTHERAPEUTICS Cmn 03969K108 265,932 -175,580 -39.77 6,353 -47.27 0.0013
2021-08-16 2021-06-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 441,512 -10,944 -2.42 12,049 -7.95 0.0027
2021-05-21 2021-03-31 13F/A-1 ARCUTIS BIOTHERAPEUTICS COM 03969K108 452,456 318,753 238.40 13,089 248.02 0.0032
2021-05-17 2021-03-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 452,456 318,753 13,089 0.0032
2021-02-16 2020-12-31 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 133,703 118,353 771.03 3,761 735.78 0.0010
2020-11-16 2020-09-30 13F ARCUTIS BIOTHERAPEUTICS COM 03969K108 15,350 -17,739 -53.61 450 -55.00 0.0001
2020-08-14 2020-06-30 13F ARCUTIS BIOTHERAPEUTICS Cmn 03969K108 33,089 -22,476 -40.45 1,000 -39.61 0.0004
2020-05-15 2020-03-31 13F ARCUTIS BIOTHERAPEUTICS Cmn 03969K108 55,565 55,565 1,656 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 56,900 -49.20 1,341 -58.79 n/a n/a n/a
2026-02-17 2025-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 112,000 71.25 3,252 163.96 n/a n/a n/a
2025-11-14 2025-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 65,400 -21.49 1,233 5.57 n/a n/a n/a
2025-08-14 2025-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 83,300 -15.77 1,168 -24.51 n/a n/a n/a
2025-05-15 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 98,900 63.74 1,547 83.83 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 60,400 -32.66 841 0.84 n/a n/a n/a
2024-11-14 2024-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 89,700 11.71 834 11.80 n/a n/a n/a
2024-08-14 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 80,300 -5.53 747 -11.40 n/a n/a n/a
2024-05-15 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 85,000 758.59 842 2,616.13 n/a n/a n/a
2024-02-14 2023-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 9,900 -13.16 32 -48.33 n/a n/a n/a
2023-11-14 2023-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 11,400 -70.31 61 -83.56 n/a n/a n/a
2023-08-14 2023-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 38,400 116.95 366 88.14 n/a n/a n/a
2023-05-15 2023-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 17,700 39.37 195 3.74 n/a n/a n/a
2023-02-14 2022-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 12,700 188 n/a n/a n/a
2022-11-14 2022-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 17,900 -49.86 381 -44.62 n/a n/a n/a
2022-05-16 2022-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 35,700 94.02 688 80.10 n/a n/a n/a
2022-02-14 2021-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Call 18,400 116.47 382 88.18 n/a n/a n/a
2021-11-15 2021-09-30 13F ARCUTIS BIOTHERAPEUTICS Cmn Call 8,500 -47.20 203 -53.76 n/a n/a n/a
2021-08-16 2021-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Call 16,100 439 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 25,700 -24.19 605 -38.52 n/a n/a n/a
2026-02-17 2025-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 33,900 25.09 984 92.94 n/a n/a n/a
2025-11-14 2025-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 27,100 -36.08 511 -14.14 n/a n/a n/a
2025-08-14 2025-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 42,400 38.56 594 24.27 n/a n/a n/a
2025-05-15 2025-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 30,600 6.62 479 19.80 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 28,700 -12.50 400 30.82 n/a n/a n/a
2024-11-14 2024-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 32,800 57.69 305 58.03 n/a n/a n/a
2024-08-14 2024-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 20,800 -84.72 193 -85.68 n/a n/a n/a
2024-05-15 2024-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 136,100 158.25 1,349 692.94 n/a n/a n/a
2024-02-14 2023-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 52,700 114.23 170 30.77 n/a n/a n/a
2023-11-14 2023-09-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 24,600 21.18 131 -32.64 n/a n/a n/a
2023-08-14 2023-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 20,300 130.68 193 101.04 n/a n/a n/a
2023-05-15 2023-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 8,800 -3.30 97 -28.36 n/a n/a n/a
2023-02-14 2022-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 9,100 135 n/a n/a n/a
2022-05-16 2022-03-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F ARCUTIS BIOTHERAPEUTICS COM Put 14,600 29.20 303 12.22 n/a n/a n/a
2021-11-15 2021-09-30 13F ARCUTIS BIOTHERAPEUTICS Cmn Put 11,300 29.89 270 13.92 n/a n/a n/a
2021-08-16 2021-06-30 13F ARCUTIS BIOTHERAPEUTICS COM Put 8,700 237 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.